180
Views
10
CrossRef citations to date
0
Altmetric
Review

Long term efficacy and safety of etanercept in the treatment of psoriasis and psoriatic arthritis

, &
Pages 169-182 | Published online: 17 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Francesca Prignano, Jaeyun Choi, Burkhard Pieper & Lars Iversen. (2021) Anti-tumor necrosis factor agents in psoriasis: addressing key challenges using biosimilars. Expert Opinion on Biological Therapy 21:1, pages 75-80.
Read now
Chen Yang, Zhu Daoping, Xiong Xiaoping, Liu Jing & Zhang Chenglong. (2020) Magnesium oil enriched transdermal nanogel of methotrexate for improved arthritic joint mobility, repair, and reduced inflammation. Journal of Microencapsulation 37:1, pages 77-90.
Read now
Christoforos Vlachos, Georgios Gaitanis, Konstantinos H Katsanos, Dimitrios K Christodoulou, Epameinondas Tsianos & Ioannis D Bassukas. (2016) Psoriasis and inflammatory bowel disease: links and risks. Psoriasis: Targets and Therapy 6, pages 73-92.
Read now
Rehab Monir Samaka, Mohamed A. Gaber & Nermin A. Metwe. (2015) Perforin Expression in Plaque Psoriasis: An Immunohistochemical Study. Ultrastructural Pathology 39:2, pages 110-120.
Read now

Articles from other publishers (6)

Vanessa T. Trossmann, Stefanie Heltmann-Meyer, Hanna Amouei, Harald Wajant, Raymund E. Horch, Dominik Steiner & Thomas Scheibel. (2022) Recombinant Spider Silk Bioinks for Continuous Protein Release by Encapsulated Producer Cells. Biomacromolecules 23:10, pages 4427-4437.
Crossref
Nicola Humphry. (2022) The Efficacy of Anti-TNFs in Immune-Mediated Disease. EMJ Gastroenterology, pages 2-9.
Crossref
Aina Akmal Mohd Noor, Maryam Azlan & Norhanani Mohd Redzwan. (2022) Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action. Biomedicines 10:2, pages 498.
Crossref
Yufang Liu, Guifang Qin, Zudong Meng, Tianping Du, Xiaolan Wang, Yong Tang & Jingjing Cao. (2018) IL-1β, IL-17A and combined phototherapy predicts higher while previous systemic biologic treatment predicts lower treatment response to etanercept in psoriasis patients. Inflammopharmacology 27:1, pages 57-66.
Crossref
A. S. Botkina, N. G. Korotkij & V. N. Korotkij. (2018) Targeted therapy of psoriatic disease. Klinicheskaya dermatologiya i venerologiya 17:4, pages 18.
Crossref
Shira Cohen, Faina Barer, Inbal Itzhak, Michael H. Silverman & Pnina Fishman. (2018) Inhibition of IL-17 and IL-23 in Human Keratinocytes by the A 3 Adenosine Receptor Agonist Piclidenoson . Journal of Immunology Research 2018, pages 1-8.
Crossref